Coronavirus company news summary – Flowserve to support Pfizer’s vaccine production – MKesson helps J&J distribute its vaccine in the US

2 March 2021 (Last Updated March 2nd, 2021 08:46)

2 March 2021

Flowserve Corporation is providing pumps, valves, and seals to Pfizer to support the production of its Covid-19 vaccine. Pfizer needed immediate support to replace a mechanical mixer seal on its Covid-19 vaccine production line, which Flowserve has rebuilt. The company will also provide Pfizer with a cryogenic valve application to support their expanded production capabilities of the vaccine.

Healthcare supply chain management company MKesson has begun distributing Johnson & Johnson (J&J)‘s  Janssen Covid-19 vaccine in the US. The Janssen vaccine was granted emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) last week and is the first one-shot Covid-19 vaccine authorised in the US.

Sorrento Therapeutics and its subsidiary Scilex have entered into an exclusive licensing agreement with Aardvark Therapeutics to acquire the latter’s proprietary formulation Delayed Burst Release Low Dose Naltrexone (DBR-LDN), or ARD-301, to treat chronic pain, fibromyalgia, and chronic post-Covid syndrome. This study will be conducted in multiple Phase II programmes planned for this year.